Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pulmonary Disease Specialists, P.A. is a specialized medical group and clinical research organization headquartered in Kissimmee, Florida, with additional locations in Davenport and Clermont. Founded in 1985 and currently operating as part of the Optum network, the company provides comprehensive care in pulmonary, critical care, and sleep medicine. Through its dedicated research arm, PDS Research, the organization serves as a high-volume site for Phase II-IV clinical trials, collaborating with global pharmaceutical leaders such as Pfizer, AstraZeneca, and GSK. The practice specializes in the diagnosis and management of chronic respiratory conditions, including asthma, COPD, and idiopathic pulmonary fibrosis, as well as sleep-related disorders. PDS Research utilizes state-of-the-art facilities, including accredited sleep centers and advanced pulmonary function testing labs, to evaluate novel therapeutic candidates and medical devices. The organization is recognized for its commitment to advancing respiratory medicine through both direct patient care and clinical innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pulmonary Disease Specialists.